NYT Declined Zyprexa Court Invitation_Secrecy’s Dangerous SideEffects
"When legal settlements allow companies to hide their mistakes, what we don't know can hurt us."
SEC Filings: Eli Lilly Admits Problems Getting Liability Insurance For Zyprexa
These illegal practices are the secret behind this toxic drug–Zyprexa– becoming a blockbuster seller.
FDA Proposals Fail to Ensure Independent Drug Safety Assessment
In essence FDA proposals merely change the seating arrangement on the deck of the sinking Titanic. Eli Lilly announced that it intends to seek FDA approval for a long-lasting injectable form of Zyprexa (taken once a month).
Transcript Zyprexa Litigation
Read: Transcript of Hearing Re: RE: ZYPREXA LITIGATION, MDL 04 1596 in U.S.
District Court Eastern District of NEW YORK
Canadian Study: SSRI Increase Bone Fracture Risk
"Daily use of SSRIs was also associated with a four per cent reduction in bone mineral density of the hip and 2.4 per cent of the lower spine, the study found."
Legal Brief on Behalf of AHRP Re: Lilly-Zyprexa Documents
AHRP legal brief: "The Injunction is not in the public interest, as any injunction must be. The important data in the Lilly- Zyprexa Documents and the long history of cover-ups by “Big Pharma” make this clear."
Lilly -Zyprexa Casualties-$1.2 Billion Settlements-More Casualties_NYT_WSJ
Eli Lilly's latest Zyprexa settlement will not affect civil or criminal investigations pending over Zyprexa from state attorneys general and federal prosecutors, which are continuing.
Zyprexa Sales Rep on YouTube: A Video You Must See
Spread the word! See and pass along: "Zyprexa Sales Rep" posted on YouTube:
http://www.youtube.com/watch?v=nj0LZZzrcrs
Public Testimonies at FDA-SSRI-Suicidality Hearings, Dec. 13, 2006
Only if one assumes that the FDA sees the drug industry as its client can some sense be made of December 13th meeting of the FDA’s Psychopharmacologic Drugs Advisory Committee in Silver Springs, Maryland.
Eli Lilly Lies About Zyprexa_NYT Editorial Calls for CongressionalHearings
The question is: will Eli Lilly succeed, once again, to divert public attention from the revelations contained in its internal documents about the company's illegal marketing practices and its failure to warn about lethal risks posed by its product?
Lilly Marketing Zyprexa Challenged by Stat AGs–NYT_Antipsychotics: Off-label Use
State Attorney Generals are investigating the off-label marketing of Zyprexa–which, if documented is a federal crime.
Documents Show Eli Lilly Lied about Zyprexa
The New York Times is calling for congressional hearings after the revelations that Eli LillyDocumented evidence reveal that Eli Lilly glossed over the debilitating hazards of Zyprexa–and aggressively marketed it to primary care physicians.